About Sensigen
Sensigen was founded in 2002 and is based in Research Triangle Park, United States. Operations focus on the womens health sector, where genetic testing services are offered for areas including hereditary cancer, pre-pregnancy, pregnancy, pediatric, and sexual health. Genetic counseling and resources are provided to patients and healthcare providers. Advanced diagnostics and screening options are supported for healthcare professionals.
- Headquarter Research Triangle Park, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sensigen
Detailed funding history for Sensigen
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Sensigen
Sensigen has secured backing from 1 investor. Prominent investors backing the company include Sequenom.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
|
Locked | Locked | Locked |
Investor details for Sensigen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sensigen
Investment portfolio details for Sensigen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sensigen
Detailed financials for Sensigen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sensigen Comparisons
Peer comparison for Sensigen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sensigen
Detailed competitors of Sensigen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sensigen
Complete news archive for Sensigen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sensigen
Sensigen was founded in 2002.
Sensigen is headquartered in United States. It is registered at North Carolina, United States.
Sensigen was founded in 2002 and is based in Research Triangle Park, United States. Operations focus on the womens health sector, where genetic testing services are offered for areas including hereditary cancer, pre-pregnancy, pregnancy, pediatric, and sexual health. Genetic counseling and resources are provided to patients and healthcare providers. Advanced diagnostics and screening options are supported for healthcare professionals.
Sensigen has 1 investor. Key investors include Sequenom.